SCHEMBL7160754

SCHEMBL7160754

Cc1oc(-c2ccccc2)nc1COc1cccc(C=CC(=O)O)c1

nearest known ligand 0.65

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.65
KDM4E B2RXH2 3/20 0.59
ALDH1A1 P00352 2/20 0.59
PKM P14618 1/20 0.59
FFAR1 O14842 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.55
MAPT P10636 3/20 0.54
PPARG P37231 6/20 0.54
PPARA Q07869 6/20 0.54
TP53 P04637 2/20 0.51
POLB P06746 1/20 0.50
CYP2C9 P11712 1/20 0.50
KCNH2 Q12809 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7160752 1.00 KDR (0.65) KDRKDM4EALDH1A1PKMFFAR1
SCHEMBL6968517 0.90 KDR (0.60) KDRKDM4EALDH1A1FFAR1SMN1; SMN2
SCHEMBL6968514 0.90 KDR (0.60) KDRKDM4EALDH1A1FFAR1SMN1; SMN2
SCHEMBL6157414 0.87 KDR (0.67) KDRFFAR1MAPTPPARGPPARA
SCHEMBL6960372 0.86 KDR (0.63) KDRFFAR1MAPTPPARGPPARA
SCHEMBL6965135 0.86 KDR (0.69) KDRFFAR1MAPTPPARGPPARA
SCHEMBL6965127 0.86 KDR (0.69) KDRFFAR1MAPTPPARGPPARA
SCHEMBL6960376 0.86 KDR (0.63) KDRFFAR1MAPTPPARGPPARA
SCHEMBL8983782 0.84 KDR (0.66) KDRFFAR1MAPTPPARGPPARA
SCHEMBL8983784 0.84 KDR (0.66) KDRFFAR1MAPTPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552058-B1 For therapy of diabetes or hyperlipidemia TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-04-22 US disclosed
US-6147099-A USEFUL AS ANTI-DIABETICS OR HYPOLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2000-11-14 US disclosed
US-5972970-A COMPOUNDS SUCH AS 5-(3-(2-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL) ETHOXYL-5-PYRIDYL)PROPYL)-2,4-OXAZOLIDINEDIONE; ADMINISTERING TO TREAT A MAMMAL SUFFERING FROM DIABETES OR HYPERLIPIDEMIA TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-10-26 US disclosed
EP-0612743-B1 Oxazolidinedione derivatives, their production and use in lowering blood sugar and lipid levels TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-09-10 EP disclosed
US-5665748-A ANTIDIABETIC, HYPOLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-09-09 US disclosed
EP-0612743-A1 Oxazolidinedione derivatives, their production and use in lowering blood sugar and lipid levels TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-08-31 EP disclosed